biotech licensing: <br />James Hatton: February 12, 2007: Abiomed; ImmunoGen; Palatin AstraZeneca; &c.

<body> <iframe src="http://www2.blogger.com/navbar.g?targetBlogID=6223270&blogName=biotech+licensing%3A+James+Hatton&publishMode=PUBLISH_MODE_FTP&navbarType=BLUE&layoutType=CLASSIC&homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2Findex.html&searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" height="30px" width="100%" marginwidth="0" marginheight="0" scrolling="no" id="navbar-iframe" frameborder="0"></iframe> <div id="space-for-ie"></div>

Tuesday, February 13, 2007

February 12, 2007: Abiomed; ImmunoGen; Palatin AstraZeneca; &c.

0 Comments:

Links to this post:

<$BlogBacklinkTitle$>: <$BlogBacklinkSnippet$>
posted by <$BlogBacklinkAuthor$> @ <$BlogBacklinkDateTime$>